首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Bronchiolitis obliterans syndrome and restrictive allograft syndrome: Do risk factors differ?
【24h】

Bronchiolitis obliterans syndrome and restrictive allograft syndrome: Do risk factors differ?

机译:闭塞性细支气管炎综合征和同种异体移植受限综合征:危险因素是否有所不同?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Chronic rejection is the major problem hampering long-term survival after lung transplantation. Recently, it became clear that patients may develop an obstructive (bronchiolitis obliterans syndrome [BOS]) or a restrictive lung function defect (restrictive allograft syndrome [RAS]), for which specific risk factors are unknown. METHODS: A retrospective analysis of our lung transplantation cohort was performed (n=380). Patients with an irreversible decline in forced expiratory volume in 1 second were identified and classified as BOS or RAS. Patient characteristics, bronchoalveolar lavage (BAL) cellularity, rates of respiratory tract infection, colonization, acute rejection, and lymphocytic bronchiolitis were compared between BOS, RAS, and stable patients. RESULTS: There were 103 patients suffering from chronic rejection, of which 79 had BOS and 24 were diagnosed with RAS. There were more patients with infection and pseudomonal colonizations in BOS and RAS compared with control (P=0.0090 and P=0.0034, respectively). More patients ever experienced acute and severe acute rejections (A≥2; both P<0.0001) and lymphocytic bronchiolitis (P=0.0006) in BOS and RAS versus control. There were more patients experiencing severe lymphocytic bronchiolitis in RAS compared with BOS (P=0.031). BAL neutrophilia in BOS and RAS were elevated at days 360, 540, and 720 versus control. BOS, but especially RAS patients, experienced more frequent episodes of increased BAL eosinophilia (≥2%; P<0.0001). CONCLUSION: Acute rejection, lymphocytic bronchiolitis, colonization with pseudomonas, infection, and BAL eosinophilia and neutrophilia are risk factors for the later development not only of RAS but also of BOS.
机译:背景:慢性排斥反应是阻碍肺移植术后长期生存的主要问题。最近,很明显,患者可能会发展为梗阻性疾病(闭塞性细支气管炎综合征[BOS])或限制性肺功能缺陷(限制性同种异体移植综合征[RAS]),具体危险因素尚不清楚。方法:对我们的肺移植队列进行回顾性分析(n = 380)。 1秒内强制呼气量不可逆转下降的患者被确定为BOS或RAS。比较了BOS,RAS和稳定患者的患者特征,支气管肺泡灌洗(BAL)细胞率,呼吸道感染率,定植,急性排斥反应和淋巴细胞性细支气管炎。结果:共有103例患有慢性排斥反应的患者,其中79例患有BOS,24例被诊断为RAS。与对照组相比,BOS和RAS感染和假性菌落定植的患者更多(分别为P = 0.0090和P = 0.0034)。与对照相比,更多的患者在BOS和RAS中经历了急性和重度急性排斥反应(A≥2; P <0.0001)和淋巴细胞性毛细支气管炎(P = 0.0006)。与BOS相比,RAS中发生严重淋巴细胞性细支气管炎的患者更多(P = 0.031)。与对照组相比,在第360、540和720天,BOS和RAS中的BAL中性粒细胞增多。 BOS,尤其是RAS患者,发生BAL嗜酸性粒细胞增多的频率更高(≥2%; P <0.0001)。结论:急性排斥反应,淋巴细胞性细支气管炎,假单胞菌定植,感染以及BAL嗜酸性粒细胞增多和中性粒细胞增多是RAS和BOS后期发展的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号